Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: Implications for cancer therapy

Kalia Vijay K, Prabhakara S, Narayanan Vidya

Year : 2009| Volume: 5| Issue : 9 | Page no: 57-60

   This article has been cited by
 
1 Radiotherapy-induced metabolic hallmarks in the tumor microenvironment
Anjali Mittal, Minal Nenwani, Itisam Sarangi, Abhinav Achreja, Theodore S. Lawrence, Deepak Nagrath
Trends in Cancer. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
Mattia Zaffaroni, Maria Giulia Vincini, Giulia Corrao, Giulia Marvaso, Matteo Pepa, Giuseppe Viglietto, Nicola Amodio, Barbara Alicja Jereczek-Fossa
International Journal of Molecular Sciences. 2022; 23(19): 11343
[Pubmed]  [Google Scholar] [DOI]
3 Assessment of Radiation Resistance and Therapeutic Targeting of Cancer Stem Cells: A Raman Spectroscopic Study of Glioblastoma
Srividya Kumar, Abhirami Visvanathan, Arimappamagan Arivazhagan, Vani Santhosh, Kumaravel Somasundaram, Siva Umapathy
Analytical Chemistry. 2018; 90(20): 12067
[Pubmed]  [Google Scholar] [DOI]
4 High glycolytic activity of tumor cells leads to underestimation of electron transport system capacity when mitochondrial ATP synthase is inhibited
Juliana S. Ruas, Edilene S. Siqueira-Santos, Erika Rodrigues-Silva, Roger F. Castilho
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
5 Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
Lili Guo, Alexander A. Shestov, Andrew J. Worth, Kavindra Nath, David S. Nelson, Dennis B. Leeper, Jerry D. Glickson, Ian A. Blair
Journal of Biological Chemistry. 2016; 291(1): 42
[Pubmed]  [Google Scholar] [DOI]
6 Targeting glucose metabolism in cancer: a new class of agents for loco-regional and systemic therapy of liver cancer and beyond?
Lynn Jeanette Savic, Julius Chapiro, Gregor Duwe, Jean-François Geschwind
Hepatic Oncology. 2016; 3(1): 19
[Pubmed]  [Google Scholar] [DOI]
7 Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer
Jermaine Coward,Angus Harding
Frontiers in Oncology. 2014; 4
[Pubmed]  [Google Scholar] [DOI]
8 Hyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Prudence Donovan,Kathleen Cato,Roxane Legaie,Rumal Jayalath,Gemma Olsson,Bruce Hall,Sarah Olson,Samuel Boros,Brent A. Reynolds,Angus Harding
Molecular BioSystems. 2014; 10(4): 741
[Pubmed]  [Google Scholar] [DOI]
9 Is Cancer a Metabolic Disease?
Hilary A. Coller
The American Journal of Pathology. 2013;
[Pubmed]  [Google Scholar] [DOI]
10 Enhanced Radiosensitivity and Chemosensitivity of Breast Cancer Cells by 2-Deoxy-D-Glucose in Combination Therapy
Fahimeh Aghaee,Jalil Pirayesh Islamian,Behzaad Baradaran
Journal of Breast Cancer. 2012; 15(2): 141
[Pubmed]  [Google Scholar] [DOI]
11 Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
Tineke W.H. Meijer, Johannes H.A.M. Kaanders, Paul N. Span, Johan Bussink
Clinical Cancer Research. 2012; 18(20): 5585
[Pubmed]  [Google Scholar] [DOI]
12 Non-cytotoxic radiosensitizers in brain radiotherapy: Journey till the first decade of this millennium
Mohindra, P., Sinha, R.N., Andrews, R.J., Khuntia, D.
Current Cancer Drug Targets. 2012; 12(3): 260-278
[Pubmed]  [Google Scholar]
13 Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response
Richardson, E., Stockwell, S.R., Li, H., Aherne, W., Cuomo, M.E., Mittnacht, S.
PLoS ONE. 2012; 7(2): art-e31627
[Pubmed]  [Google Scholar]

 

Read this article